🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to assess the efficacy, safety of MRG003 as ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-09-04
Trial ID
NCT04838548
Treatments Being Tested
To determine the recommended Phase IIa dose (RP2D) of the triplet combinati...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2024-12-31
Trial ID
NCT06683755
Treatments Being Tested
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
The goal of this clinical trial is to address care gaps for participants at...
Status
Enrolling By Invitation
Location
HealthPartners Medical Group
Start Date
2025-07-09
Trial ID
NCT06914726
Treatments Being Tested
Nurses Taking on Readiness Measures (N-TORM) is an innovative nurse-driven ...
Status
Completed
Location
Hunter College, City University of New York
Start Date
2023-07-13
Trial ID
NCT05544578
Treatments Being Tested
Cervical cancer is the most common cause of death from gynecological cancer...
Status
Active Not Recruiting
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2019-05-01
Trial ID
NCT03955185
Treatments Being Tested
The purpose of this phase II clinical study is to test the good and bad eff...
Status
Completed
Location
Memorial Sloan Kettering Monmouth
Start Date
2016-06-21
Trial ID
NCT02819843
Treatments Being Tested
To evaluate the efficacy of once daily dosing with SPARC's novel ophthalmic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-06-10
Trial ID
NCT03927443
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
This research study is designed to evaluate the safety, tolerability, and e...
Status
Terminated
Location
UCLA Stroke Network
Start Date
2004-09
Trial ID
NCT00272909
Treatments Being Tested